Next Article in Journal
A Comparative Pharmacokinetic Analysis of Oral and Subcutaneous Meloxicam Administered to Postpartum Dairy Cows
Previous Article in Journal
A Cellular Model of Infection with Brucella melitensis in Ovine Macrophages: Novel Insights for Intracellular Bacterial Detection
Open AccessArticle

Evaluation of the Effects of Undenatured Type II Collagen (UC-II) as Compared to Robenacoxib on the Mobility Impairment Induced by Osteoarthritis in Dogs

1
Department of Emergency and Organ Transplantation, PhD in Tissues and Organs Transplantation and Cellular Therapies, University of Bari, 70010 Bari, Italy
2
Department of Emergency and Organ Transplantation, Section of Veterinary Clinics and Animal Production, University of Bari, 70010 Bari, Italy
3
Department of Biomedical Sciences and Human Oncology, University of Bari, 70010 Bari, Italy
*
Author to whom correspondence should be addressed.
Vet. Sci. 2019, 6(3), 72; https://doi.org/10.3390/vetsci6030072
Received: 15 July 2019 / Revised: 27 August 2019 / Accepted: 29 August 2019 / Published: 4 September 2019
Osteoarthritis (OA) is a chronic disease that requires a multimodal therapeutic approach. The aim of this study was to evaluate the effects of undenatured type II collagen (UC-II) as compared to robenacoxib in dogs affected by OA. Our hypothesis was that the two compounds would be similar (non-inferiority) in improving mobility. To test this hypothesis, a complete orthopedic examination, x-ray and the Liverpool Osteoarthritis in Dogs (LOAD) survey were performed in dogs affected by OA before and after the treatments. The study was designed as a clinical, randomized, controlled and prospective study. Sixty client-owned dogs were randomized in the R group (n = 30, robenacoxib 1 mg/kg/day for 30 days) and in the UC-II group (n = 30, UC-II 1 tablet/day for 30 days). Thirty days after the beginning of the treatment (T30), the dogs were reassessed for the LOAD, MOBILITY and CLINICAL scores. Based on the data obtained from the study, a significant reduction in LOAD and MOBILITY scores was recorded between T0 and T30 with a similar magnitude among the two groups (R = 31.5%, p < 0.001; UC-II = 32.7%, p = 0.013). The results of this study showed that UC-II and robenacoxib were able to similarly improve mobility of dogs affected by OA. View Full-Text
Keywords: osteoarthritis in dogs; chronic disease; management of pain; multimodal analgesia osteoarthritis in dogs; chronic disease; management of pain; multimodal analgesia
Show Figures

Figure 1

MDPI and ACS Style

Stabile, M.; Samarelli, R.; Trerotoli, P.; Fracassi, L.; Lacitignola, L.; Crovace, A.; Staffieri, F. Evaluation of the Effects of Undenatured Type II Collagen (UC-II) as Compared to Robenacoxib on the Mobility Impairment Induced by Osteoarthritis in Dogs. Vet. Sci. 2019, 6, 72.

Show more citation formats Show less citations formats
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop